Skip to main content

Cidofovir

J - Antiinfectives For Systemic Use -> J05 - Antivirals For Systemic Use -> J05A - Direct Acting Antivirals -> J05AB - Nucleosides And Nucleotides Excl. Reverse Transcriptase Inhibitors -> J05AB12 - Cidofovir
Administration category: Limited Medicine group: antiviral

Standard dosages

Weight ROA Load Dosage
ROA:
po
Load:
-
Dosage:
Comments:

5mg/kg cidofovir 1x per week gedurende 2 weken, vervolgens 5mg/kg 1x per week

Kidney function

ROA GFR Dosage Interval Comments
ROA:

Notes GFR general:

Nefroprotectieve maatregelen: voor elke cidovofir-infusie prehydreren met 1½L NaCl 0.9% in 1½h, daarna nog eens 500 ml NaCl 0.9% gelijktijdig met de cidofovir-infusie in laten inlopen. Voor en na elke cidovofir toediening tevens probenecid voorschrijven: 2 gram per os 3 uur voor en 1 gram per os 2 uur en 8 uur (in totaal 4 gram) na cidofovir toediening.
Dosage: dependent on kidney function

Renal function-replacement therapy

CAPD: 0,5 mg/kg/dosis, zonder probenecid

Hemo dialysis: Standaard inductie of onderhoudsdosis; 2 uur vóór hemodialyse, zonder probenecid

CAV / VVHD: 1x per week 3-4 mg/kg gedurende 2 weken Vervolgens: 1x per twee weken 3-4 mg/kg

Pregnancy

Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:

For individual advice, consult an expert on site.

General comments

Brody SR, Humphreys MH, Gambertoglio JG, Schoenfeld P, Cundy KC, Aweeka FT. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis. Clin Pharmacol Ther. 1999;65(1):21-28. doi:10.1016/S0009-9236(99)70118-9

Vossen MG, Gattringer KB, Jager W, et al: Single-dose pharmacokinetics of cidofovir in continuous venovenous hemofiltration. Antimicrob Agents Chemother 2014; 58(4):1952-1955

Metadata

Swab vid: M-501429.1
Updated: 01/31/2023 - 15:25
Status: Published

Menu position